Found: 18
Select item for more details and to access through your institution.
Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 5, p. 797, doi. 10.1002/alz.12058
- By:
- Publication type:
- Article
P4‐014: ESTIMAND IN EARLY ALZHEIMER'S DISEASE: PROGRESS UPDATE FROM THE INTERNATIONAL ALZHEIMER'S DISEASE SCIENTIFIC WORKING GROUP (AD SWG) SUBSTREAM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1437, doi. 10.1016/j.jalz.2018.06.2416
- By:
- Publication type:
- Article
DELAYED-START ANALYSES IN THE PHASE 3 SOLANEZUMAB EXPEDITION3 STUDY IN MILD ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1260, doi. 10.1016/j.jalz.2017.06.1881
- By:
- Publication type:
- Article
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 2, p. 110, doi. 10.1016/j.jalz.2015.06.1893
- By:
- Publication type:
- Article
Delayed-start analyses of up to 3.5 years in the phase 3 solanezumab expedition program in mild Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P262, doi. 10.1016/j.jalz.2015.07.338
- By:
- Publication type:
- Article
Delayed-start analyses of solanezumab phase 3 expedition studies in mild Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P852, doi. 10.1016/j.jalz.2014.05.1689
- By:
- Publication type:
- Article
Cognition Impairment Precedes and Predicts Functional Impairment in Mild Alzhiemer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P621, doi. 10.1016/j.jalz.2014.05.1070
- By:
- Publication type:
- Article
Cognitive impairment precedes and predicts functional impairment in mild alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P203, doi. 10.1016/j.jalz.2014.04.256
- By:
- Publication type:
- Article
A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119632
- By:
- Publication type:
- Article
Osteopenia Associated with Increased Prolactin and Aging in Psychiatric Patients Treated with Prolactin-Elevating Antipsychotics.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1032, n. 1, p. 297, doi. 10.1196/annals.1314.044
- By:
- Publication type:
- Article
Longitudinal Effect of Olanzapine on Fasting Serum Lipids: A Randomized, Prospective, 4-Month Study.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1032, n. 1, p. 295, doi. 10.1196/annals.1314.043
- By:
- Publication type:
- Article
Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.
- Published in:
- BMC Psychiatry, 2011, v. 11, n. 1, p. 87, doi. 10.1186/1471-244X-11-87
- By:
- Publication type:
- Article
A Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee.
- Published in:
- Pain Practice, 2011, v. 11, n. 1, p. 33, doi. 10.1111/j.1533-2500.2010.00401.x
- By:
- Publication type:
- Article
Alzheimer's disease progression by geographical region in a clinical trial setting.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0127-0
- By:
- Publication type:
- Article
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0122-5
- By:
- Publication type:
- Article
Poster 6: Duloxetine 60 to 120 mg Once Daily Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 6: Duloxetine 60 to 120 mg Once Daily Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
- Published in:
- BMC Medicine, 2005, v. 3, p. 21, doi. 10.1186/1741-7015-3-21
- By:
- Publication type:
- Article